The KEGG pathway analysis showed that the identified DEGs were mainly enriched in the following top five pathways: proteoglycans in cancer, bladder cancer, malaria, tyrosine kinase inhibitor resistance in EGFR, and the ERBB signaling pathway. The gene discussed is EGFR; the disease is cancer.